epidermal growth factor receptor

Open Access
Phase Ib study of anti-EGFR antibody (SCT200) in combination with anti-PD-1 antibody (SCT-I10A) for patients with RAS/BRAF wild-type metastatic colorectal cancer
Ming Bai, Yao Lu, Chunmei Shi, Jianwei Yang, Wei Li, Xianli Yin, Chenghui Huang, Lin Shen, Liangzhi Xie and Yi Ba

Cancer Biology & Medicine July 2024, 21 (7) 636-650; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0301
You have access
Safety and efficacy of anti-EGFR monoclonal antibody (SCT200) as second-line therapy in advanced esophageal squamous cell carcinoma
Ming Bai, Meng Wang, Ting Deng, Yuxian Bai, Kai Zang, Zhanhui Miao, Wenlin Gai, Liangzhi Xie and Yi Ba

Cancer Biology & Medicine March 2022, 19 (3) 358-369; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0388
You have access
Therapeutic resistance in cancer: microRNA regulation of EGFR signaling networks
German G. Gomez, Jill Wykosky, Ciro Zanca, Frank B. Furnari and Webster K. Cavenee

Cancer Biology & Medicine December 2013, 10 (4) 192-205; DOI: https://doi.org/10.7497/j.issn.2095-3941.2013.04.003
You have access
Efficacy and Immune Mechanisms of Cetuximab for the Treatment of Metastatic Colorectal Cancer
Hao ZHUANG, Zhen-yi XUE, Lu WANG, Xiao-yan LI, Ning ZHANG and Rong-xin ZHANG

Clinical Oncology and Cancer Research December 2011, 8 (4) 207-214; DOI: https://doi.org/10.1007/s11805-011-0582-8
You have access
An Investigation of the Potential Malignant Characteristics of Endometriosis
Chengxin Wang, Hongyan Zhou, Xiaonan You, Xiji Shu, Yan Li and Xiaoling Zhao

Chinese Journal of Clinical Oncology December 2005, 2 (6) 861-865;

Main menu

User menu

Search

epidermal growth factor receptor

Navigate

More Information

For Authors

Journal Services